share_log

Breaking Down Inari Medical: 9 Analysts Share Their Views

Breaking Down Inari Medical: 9 Analysts Share Their Views

分析Inari Medical: 9位分析師分享他們的觀點
Benzinga ·  10/09 21:00
In the latest quarter, 9 analysts provided ratings for Inari Medical (NASDAQ:NARI), showcasing a mix of bullish and bearish perspectives.
在最新的季度中,有9位分析師爲inari medical(納斯達克:NARI)提供了評級,展現了一系列看好和看淡的觀點。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級快照,展示了情緒在過去30天中的演變情況,並將其與之前的月份進行比較。
Analysts have set 12-month price targets for Inari Medical, revealing an average target of $58.78, a high estimate of $71.00, and a low estimate of $47.00. Observing a downward trend, the current average is 2.31% lower than the prior average price target of $60.17.
分析師爲Inari Medical設定了12個月的目標股價,顯示平均目標爲$58.78,最高預估爲$71.00,最低預估爲$47.00。觀察到一個下降趨勢,當前平均目標比之前的平均目標價格$60.17低了2.31%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級:全面解析
In examining recent analyst actions, we gain insights into...
通過審查最近的分析...

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論